MDT Financial Statements & Analysis
Complete financial statements for MDT including income statement, balance sheet, and cash flow statement. Analyze MDT's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
57
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
3.6% ↑
Net Income
26.8% ↑
Gross Margin
-0.0% ↓
Operating Margin
11.7% ↑
Balance Sheet
Current Ratio
-9.1% ↓
Debt to Equity
19.2% ↓
Asset Turnover
1.7% ↑
Cash Flow
Operating Cash Flow
3.8% ↑
Net Cash Flow
460.6% ↑
Free Cash Flow
-0.3% ↓
Cash Flow to Debt
-8.9% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
Metric | 2024 | 2025 | Change | Impact |
---|---|---|---|---|
Revenue | 32.36B | 33.54B | 3.6% | |
Gross Profit | 21.15B | 21.91B | 3.6% | |
Operating Income | 5.14B | 5.96B | 15.8% | |
Net Income | 3.68B | 4.66B | 26.8% | |
EPS | 2.77 | 3.63 | 31.0% | |
EBITDA | 8.20B | 9.22B | 12.4% | |
Gross Margin | 65.34% | 65.32% | 0.0% | |
Operating Margin | 15.89% | 17.76% | 11.7% | |
Net Income Margin | 11.36% | 13.90% | 22.4% | |
R&D Expenses | 2.73B | 2.73B | 0.1% |
Income Statement Full Table
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 33.54B | 32.36B | 31.23B | 31.69B | 30.12B |
Gross Profit | 21.91B | 21.15B | 20.51B | 21.54B | 19.63B |
Operating Income | 5.96B | 5.14B | 5.49B | 5.75B | 4.48B |
Net Income | 4.66B | 3.68B | 3.76B | 5.04B | 3.61B |
EPS | 3.63 | 2.77 | 2.83 | 3.75 | 2.68 |
EBITDA | 9.22B | 8.20B | 8.70B | 8.78B | 7.52B |
Gross Margin | 65.32% | 65.34% | 65.67% | 67.98% | 65.19% |
Operating Margin | 17.76% | 15.89% | 17.56% | 18.15% | 14.89% |
Net Income Margin | 13.90% | 11.36% | 12.03% | 15.90% | 11.97% |
R&D Expenses | 2.73B | 2.73B | 2.70B | 2.75B | 2.49B |